Related references
Note: Only part of the references are listed.SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
Phase 2 trial of Sandwich L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Ming Jiang et al.
CANCER (2012)
To SMILE or Not: Supportive Care Matters
Alexandre Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience
Huiqiang Huang et al.
LEUKEMIA & LYMPHOMA (2011)
L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type
Weiben Yong et al.
ANNALS OF HEMATOLOGY (2009)
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
B. -S. Kim et al.
ANNALS OF ONCOLOGY (2009)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
Jeeyun Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ±radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
Keun-Wook Lee et al.
LEUKEMIA & LYMPHOMA (2006)
Radiotherapy as primary treatment for stage IE and IIE nasal natural Killer/T-cell lymphoma
YX Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
Share Paper
